Loss of expression of transforming growth factor β in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion

Keyphrases

• High Risk 100%
• Transforming Growth Factor-β 100%
• Hyperproliferation 100%
• Skin Tumor 100%
• Malignant Conversion 100%
• Loss of Expression 100%
• Papilloma 29%
• Epidermis 23%
• Suprabasal 23%
• Tumor 17%
• Basal Cell 17%
• Low Risk 11%
• Malignant Progression 11%
• Proliferating Cells 11%
• Growth Properties 11%
• Tumor Promoter 11%
• Risk Factors 5%
• Regress 5%
• Biologically Relevant 5%
• Transgenic Mice 5%
• Keratinocytes 5%
• Squamous Cell Carcinoma (SqCC) 5%
• Benign Tumor 5%
• Cellular Compartments 5%
• Cell Layer 5%
• Post-transcriptional Level 5%
• Mouse Skin 5%
• Growth Inhibitor 5%
• Normal Epidermis 5%
• Keratin 13 5%
• Benign Papilloma 5%
• Epidermal Tumors 5%
• Skin Carcinoma 5%
• Basal Layer 5%
• Skin Papilloma 5%
• Hyperproliferative 5%

Medicine and Dentistry

• Skin Tumor 100%
• Transforming Growth Factor 100%
• Papilloma 35%
• Fibrinogen 29%
• Neoplasm 23%
• Prothrombin 23%
• Basal Cell 17%
• Cell Proliferation 11%
• Tumor Promoter 11%
• In Vitro 5%
• Squamous Cell Carcinoma 5%
• Benign Tumor 5%
• Cell Compartment 5%
• Transgenic Mouse 5%
• Basement Membrane 5%
• Skin Carcinoma 5%
• Growth Inhibitor 5%
• Keratin 13 5%
• Skin Papilloma 5%
• Keratinocyte 5%

Immunology and Microbiology

• Transforming Growth Factor 100%
• Basal Cell 17%
• Malignant Progression 11%
• Promoter Region 11%
• Mouse 11%
• Cell Proliferation 11%
• Transgenic Mouse 5%
• Growth Inhibitor 5%
• Squamous Cell 5%
• Wild Type 5%
• Keratinocyte 5%
• Basement Membrane 5%